|
|
||||||||
1 Department of Clinical Studies, Royal Veterinary and Agricultural University, Copenhagen, Denmark
2 Department of Immunology and Biochemistry, Danish Veterinary Institute, Copenhagen, Denmark
Corresponding author: S. Jacobsen; e-mail: stj{at}kvl.dk.
| ABSTRACT |
|---|
|
|
|---|
Key Words: lipopolysaccharide serum amyloid A haptoglobin individual variation
Abbreviation key: APP = acute phase protein(s), AUC = area(s) under the curve, SAA = serum amyloid A, TNF = tumor necrosis factor
| INTRODUCTION |
|---|
|
|
|---|
In mice, the outcome of Gramnegative infection has been shown to correlate with the capacity to mount an acute inflammatory response (Araujo et al., 1998), and in models of bovine Escherichia coli mastitis, the severity of the clinical course of infection has been linked to the individuals capacity to elicit an acute inflammatory response, for example, secretion of tumor necrosis factor (TNF)
(Sordillo et al., 1992) or induction of respiratory burst and chemotactic activity of polymorphonuclear leukocytes (Lohuis et al., 1990; Vandeputte-van Messom et al., 1993).
Lipopolysaccharides and infections with Gram-negative bacteria are known to be potent inducers of inflammation and the acute phase response, giving rise to large changes in the serum concentrations of acute phase proteins (APP) such as haptoglobin, serum amyloid A (SAA), and albumin (Boosman et al., 1989; Werling et al., 1996). The main functions of haptoglobin and SAA in the acute phase response are only known in part, but the facts that APP are highly conserved during evolution and that their serum levels change dramatically in response to a wide variety of harmful stimuli (infection, tissue injury, aseptic inflammation, cancer, etc.) suggest important roles for them in the modulation of inflammatory reactions. An individuals ability to raise an acute phase response may therefore play a role in its capacity to withstand systemic exposure to LPS. However, individual differences in the APP response in cattle have never been investigated.
The aim of the present study was to characterize the dose dependency of the LPS-induced APP response and to investigate to what extent it differs between individual cows. Eight dairy cows were each challenged 3 times by intravenous injection of low doses of LPS, and serum concentrations of haptoglobin, SAA, and albumin were measured for 144 h after each injection.
| MATERIALS AND METHODS |
|---|
|
|
|---|
On arrival, clinical examinations of udder, uterus, and limbs were performed, and cows IV and VII were subsequently treated with intramammary antibiotics. During the experimental period, clinical examinations of udder, limbs, and ears were performed daily. Mild periphlebitis of the auricular vein was diagnosed in cow VII at h 96, 120, and 144 of the 10 ng LPS/kg challenge. This was treated topically and healed in 1 wk. Cow IV was treated for mastitis at h 120 and 144 of the 1000 ng LPS/kg challenge.
One week before each challenge, cows were equipped with indwelling venous catheters (Secalon Seldy, Becton Dickinson, Brøndby, Denmark). These were inserted into one of the larger ear veins (v. auricularis intermedia or v. auricularis medialis) and passed through v. auricularis caudalis into v. jugularis ex-terna. At each blood sampling, and at least once daily, the ears were examined for inflammatory reactions, and catheters were flushed with approximately 15 mL of 0.9% sterile saline. Deposition of 1 mL of 0.9% sterile saline containing 50 IU of heparin (Løvens Kemiske Fabrik, Ballerup, Denmark) prevented clot formation. Before flushing or blood collection, the heparinized saline solution was aspirated along with approximately 5 mL of blood and discarded.
The cows were challenged 3 times with 3-wk intervals using 10, 100, and 1000 ng LPS/kg, consecutively (E. coli strain O55:B5, Westphals extraction, Sigma Chemical Co., St. Louis, MO). In each challenge, LPS was injected intravenously at 0 h through the indwelling venous catheter.
Blood was collected in 30-mL single-use syringes (B. Braun Melsungen, Melsungen, Germany) and immediately transferred to vacutainer tubes (Becton Dickinson, Vacutainer System, Brøndby, Denmark). Blood for determination of haptoglobin, SAA, and albumin concentrations was collected at 144, 0, 12, 24, 36, 48, 72, 94, 120, and 144 h after the challenge. In addition to these time points, SAA was also determined in blood samples obtained at 6 h after the challenge, and albumin was also determined at 0.5, 1, 2, 3, 4, 5, and 6 h after the challenge. A standardized clinical examination was carried out at each sampling.
Serum samples were prepared by letting the blood samples clot at room temperature for 18 h before centrifugation at 2500 x g and separation of serum. The serum samples were stored at 18°C until analysis.
Laboratory Analyses
The concentrations of SAA in the serum samples were determined in a commercially available sandwich ELISA (Tridelta Development Ltd., Greystones Co., Wicklow, Ireland) according to the manufacturers instructions. The monoclonal antibodies and the ELISA were originally described by McDonald et al. (1991). All samples including the standards were tested in duplicate. Samples were initially diluted 1:500, and samples with optical density values above the range of the standard curve were diluted further and reanalyzed. Optical density values were read on an automatic plate reader (model 550, Bio-Rad, Hercules, CA) at 450 nm with reference at 595 nm. According to the manufacturer, the detection limit of the assay was 0.3 µg/mL.
Serum haptoglobin concentrations were determined in a sandwich ELISA originally described by Godson et al. (1996) as described previously (Heegaard et al., 2000) using a pool of bovine serum as standard. The bovine serum standard was calibrated against a standard obtained from a European Union concerted action on standardization of animal APP (QLK5-CT-1999-01532). The lower detection limit of the assay, as defined by the linear range of the standard curve, was 0.5 µg/mL. The samples were tested in serial dilutions of 1:100, 1:300, and 1:900, resulting in a lower limit of detection of 50 µg haptoglobin/mL.
Serum albumin concentrations were determined by bromocresol green-binding and spectrophotometrical determination at 596 nm (ADVIA 1650, Bayer A/S, Lyngby, Denmark).
Statistical Analyses
The statistical analyses were performed as a repeated measures ANOVA using the PROC MIXED procedure of SAS (1999). The explanatory variables LPS dose-time (h after the challenge), cow identity, and the interaction between LPS dose and time were included in the model as fixed effects. The correlation structure between repeated measurements for each cow within each dose was modeled by a spatial power structure to allow for the unequal sampling intervals. The outcome variables were haptoglobin, SAA, and albumin concentrations in serum, and the ratio between haptoglobin and SAA concentrations. Assumptions were verified on residual plots and tested for normality. Serum amyloid A concentrations were logarithmically transformed to obtain normally distributed and unskewed residuals as assumed.
Differences in least squares means estimates from the repeated measurement analyses were used to identify time points or intervals at which the respective responses to 10, 100, and 1000 ng LPS/kg differed significantly and to identify significant increases from the prechallenge baseline values. Bonferronis multiple comparison procedure was used in order to control Type I errors. If not otherwise stated, a 5% level of significance was used.
Differences in residuals between the statistical model described above and a model where the variable cow identity was left out were used to estimate the amount of variation in APP concentrations explained by this variable.
Areas under the curve (AUC) were calculated for each cow as:
![]() |
where ti = time of observation, ti1 = previous time of observation, fi = SAA or haptoglobin concentrations at time i, and fi1 = SAA or haptoglobin concentrations at time i 1. Areas under the curve were used as a summary measure for serum concentrations of haptoglobin and SAA over time in comparing the overall haptoglobin and SAA responses in the challenges with 100 and 1000 ng LPS/kg. This comparison was done by linear regression, and assumptions were verified on residual plots and tested for normality.
Figure 1
showing the overall changes in haptoglobin, SAA, and albumin concentrations and Figure 6
showing the ratio between haptoglobin and SAA concentrations are based on least squares means estimates obtained in the statistical analysis, whereas Figures 2![]()
to 4
show raw data.
|
|
|
|
|
| RESULTS |
|---|
|
|
|---|
Serum concentrations of haptoglobin and SAA increased significantly above the prechallenge baseline levels in all 3 challenges (Table 1
, Figure 1
) and differed among cows (Figures 2
, 3
, and 4
). In all 3 challenges, SAA concentrations peaked and fell towards the pre-challenge levels quicker than haptoglobin concentrations (Table 1
, Figure 1
).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The serum concentrations of SAA and haptoglobin started to increase within 6 and 36 h after the challenge, respectively, and concentrations remained elevated for up to 144 h. In contrast, albumin is a negative APP, the serum concentrations of which decrease during the acute phase response. After all 3 intravenous LPS challenges, the albumin concentrations decreased in a bi-phasic manner (Figure 1
). The first decrease occurred between 1 and 6 h after LPS injection and was probably a result of an inflammation-induced increase in vascular permeability that allowed efflux of serum proteins to the perivascular tissue. The second decrease, which occurred from 36 h postchallenge onwards, was probably a reflection of decreased hepatic albumin synthesis resulting from a cytokine-induced reduction in gene transcription (Aldred and Schreiber, 1993). Albumin levels normalized within the observation period of each challenge. Nevertheless, the prechallenge levels of albumin became progressively reduced over the experimental period, and prior to the challenge with 1000 ng LPS/kg, the concentration of albumin was significantly lower than the prechallenge levels in the 2 previous challenges. The reasons for this finding could not be determined, but might be related to the slow turnover of albumin in cattle.
The APP responses were dose dependent (Table 2
). The responses of SAA, haptoglobin, and albumin were markedly increased when the LPS dose was increased from 10 to 100 ng/kg, whereas the challenge with 1000 ng LPS/kg resulted in APP responses of a similar magnitude as those seen after the challenge with 100 ng LPS/kg. It therefore seems that the APP synthesizing capacity of the liver had been reached already at the second challenge. This may reflect limitations in cytokine secretory capacity, as described by Gerros et al. (1993). In this study, serum concentrations of interleukin-1 and TNF
in calves did not reflect the LPS dose infused intravenously, and the authors suggested that cytokine secretion might be subject to a threshold effect and that the already-lowest LPS dose (200 ng/kg) had resulted in near maximal cytokine synthesis. It may also rely on the fact that the homeostatic changes in the liver during the acute phase response can only proceed to a certain extent, thus limiting the repartitioning of amino acids from albumin to APP synthesis. The results of the present study support this by demonstrating that both challenges with 100 and with 1000 ng LPS/kg seemed to induce equal levels of hypoalbuminemia.
The minimal differences in APP responses after the challenge with 100 and challenge with 1000 ng LPS/kg might also be explained by induction of LPS tolerance. It is widely acknowledged that repeated or continuous exposure to LPS leads to a state of hyporesponsiveness characterized by marked reduction in the magnitude and/or duration of LPS responses such as hyperthermia, anorexia, circulatory changes, and ruminal hypomotility. However, we believe that in the present study the cows were not rendered clinically tolerant towards the effects of LPS. First, clinical tolerance has been reported to peak 3 to 4 d after LPS exposure and then wane gradually, leaving the animals fully susceptible at approximately 7 to 21 d after the first LPS exposure (Beeson, 1947; Sanchez-Cantu et al., 1989), a feature that the present study was designed to take into account by spacing the LPS injections 3 wk apart. Second, the LPS used in the present study was prepared by Westphals extraction. This method ensures a highly purified compound, which exhibits poor antigenicity and hence induces minimal antibody-dependent tolerance (Greisman et al., 1969). Third, most of the clinical, hematological, and blood biochemical responses of the cows showed unambiguous doseresponse relationships (Jacobsen et al., accepted).
Concentrations of APP have been shown to reflect the extent of underlying tissue damage and are thus often used as indicators of disease severity (Deignan et al., 2000; Heegaard et al., 2000). However, by showing that approximately one-fourth of the variation in the serum concentrations of APP could be attributed to the individual, the results of the present study demonstrate that, in addition to the doseresponse relationship with LPS, the APP concentrations achieved during an acute phase response are highly dependent on the individual animal. A pronounced individual variation in the clinical response to Gram-negative infections and LPS challenges in cattle have been described previously (Michaels et al., 1988; Hirvonen et al., 1999), but this is the first study to evaluate individual variation in the APP response to LPS. Some previous studies have also failed to demonstrate a clear doseresponse relationship between intensity of the stimulus or extent of tissue damage and the resulting APP concentrations. For example, in cattle with respiratory tract disease, APP responses were very variable and not or only to a limited degree associated with the severity of clinical or subclinical disease, effect of treatment, or pulmonary lesions detected at slaughter (Wittum et al., 1996; Gånheim et al., 2003). The individual variation in APP response to LPS may be related both to the genotype of the cow and to the metabolism and disease status of the cow, as hepatic protein synthesizing capacity may be influenced by a number of pathological conditions or physiological states. By demonstrating that the individual APP responses in 2 consecutive challenges were quantitatively similar (Figure 5
), the results of the present study suggest that some cows may have an innately higher APP response than others.
The significance of the individual differences in the APP response remains to be elucidated. Serum amyloid A and haptoglobin have been suggested to play important roles in modulation of the inflammatory response (Linke et al., 1991; Rossbacher et al., 1999; Badolato et al., 2000), and the ability to synthesize APP may thus play a role in the ability of the cow to withstand harmful effects of an inflammatory insult. Acute phase proteins have previously been shown to protect mice against a lethal challenge of Gram-negative bacteria or LPS (Alcorn et al., 1992; Vogels et al., 1993), suggesting that an appropriately orchestrated acute phase response could be involved in determining the outcome of LPS-mediated disease.
In cattle, SAA is generally perceived as an indicator of acute inflammation, whereas haptoglobin is more slowly reacting and thus reflects the presence of chronic inflammatory conditions (Alsemgeest et al., 1994; Horadagoda et al., 1999). This relationship has been demonstrated in experimental models involving LPS (Werling et al., 1996), bacteria (Hirvonen et al., 1999), and virus (Heegaard et al., 2000). The results of the present study concur, as SAA concentrations started to increase and peaked before haptoglobin levels, and haptoglobin levels remained elevated above the prechallenge baseline levels for a longer time than SAA (Figure 1
). This resulted in an overall increase in the haptoglobin-to-SAA ratio over the course of the challenges (Figure 6
). However, numerically large (yet not statistically significant) individual differences were found in the haptoglobin-to-SAA ratios at each sampling time after the challenge (data not shown), indicating that care should be exercised when interpreting haptoglobin-to-SAA ratios in terms of chronicity and thus likelihood of successful treatment of disease as suggested previously (Gruys et al., 1993). A recent study on experimentally induced acute and chronic Staphylococcus aureus mastitis demonstrated that SAA and haptoglobin responses had similar time courses (Grönlund et al., 2003), and SAA and haptoglobin profiles may thus differ between different types of infection or inflammation.
In contrast to what has been shown previously in calves inoculated with bovine respiratory syncytial virus (Heegaard et al., 2000), a large SAA response in an individual cow was not correlated with a large haptoglobin response in the same cow. This indicates that SAA and haptoglobin synthesis in response to LPS are regulated in different ways in the bovine. The ideal cytokine combinations for induction of SAA and haptoglobin have been investigated in bovine hepatocyte cultures. Alsemgeest et al. (1996) showed that SAA synthesis could be induced by either of the cytokines IL-6 and TNF
, whereas a combination of both was required for haptoglobin to be synthesized. Steroid hormones such as dexamethasone or cortisol have also been shown to induce or have a permissive effect on haptoglobin synthesis in bovine hepatocytes (Higuchi et al., 1994; Alsemgeest et al., 1996). Given the complexity of the cytokine network, it is very likely that the cytokine combination optimal for SAA synthesis in vivo is different from the combination inducing maximal haptoglobin synthesis.
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication January 27, 2004. Accepted for publication May 25, 2004.
| REFERENCES |
|---|
|
|
|---|
. Hepatology 15:122129.[Medline]
and nitrite/nitrate responses during acute mastitis induced by Escherichia coli infection and endotoxin in dairy cows. Dom. Anim. Endocrinol. 19:223235.[Medline]
on the production of tumor necrosis factor during acute Escherichia coli mastitis. J. Dairy Sci. 75:21192125.[Abstract]
This article has been cited by other articles:
![]() |
M. H. Kim, C. H. Yun, J. Y. Ko, J. S. Kang, H. S. Kim, S. J. Kang, W. S. Lee, J. H. Kim, and J. K. Ha Changes of immunophysiological characteristics in neonatal calves experimentally challenged with mixture of live bacteria and virus J Dairy Sci, November 1, 2009; 92(11): 5534 - 5543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zebeli and B. N. Ametaj Relationships between rumen lipopolysaccharide and mediators of inflammatory response with milk fat production and efficiency in dairy cows J Dairy Sci, August 1, 2009; 92(8): 3800 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carroll, R. R. Reuter, C. C. Chase Jr, S. W. Coleman, D. G. Riley, D. E. Spiers, J. D. Arthington, and M. L. Galyean Profile of the bovine acute-phase response following an intravenous bolus-dose lipopolysaccharide challenge Innate Immunity, April 1, 2009; 15(2): 81 - 89. [Abstract] [PDF] |
||||
![]() |
B. N. Ametaj, K. M. Koenig, S. M. Dunn, W. Z. Yang, Q. Zebeli, and K. A. Beauchemin Backgrounding and finishing diets are associated with inflammatory responses in feedlot steers J Anim Sci, April 1, 2009; 87(4): 1314 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vels, C. M. Rontved, M. Bjerring, and K. L. Ingvartsen Cytokine and acute phase protein gene expression in repeated liver biopsies of dairy cows with a lipopolysaccharide-induced mastitis J Dairy Sci, March 1, 2009; 92(3): 922 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jacobsen and M. Kjelgaard-Hansen Evaluation of a commercially available apparatus for measuring the acute phase protein serum amyloid A in horses Vet Rec., September 13, 2008; 163(11): 327 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ask, E. H. van der Waaij, and S. C. Bishop Modeling Variability in Immunocompetence and Immunoresponsiveness Poult. Sci., September 1, 2008; 87(9): 1748 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ask, E. H. van der Waaij, E. J. Glass, and S. C. Bishop Modeling Immunocompetence Development and Immunoresponsiveness to Challenge in Chicks Poult. Sci., July 1, 2007; 86(7): 1336 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Gozho, D. O. Krause, and J. C. Plaizier Ruminal Lipopolysaccharide Concentration and Inflammatory Response During Grain-Induced Subacute Ruminal Acidosis in Dairy Cows J Dairy Sci, February 1, 2007; 90(2): 856 - 866. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |